Research Article
In-Hospital Mortality and Its Predictors among Hospitalized Diabetes Patients: A Prospective Observational Study
Table 6
Patterns of medication use among diabetic patients admitted to JMC from October 01, 2020, to June 30, 2021.
| Types of medications | Frequency n = 120 | (%) |
| Anti-infectives | Cephalosporins | 63 | 52.50 | Vancomycin | 23 | 19.16 | Metronidazole | 19 | 15.83 | Penicillin’s | 15 | 12.50 | Tetracyclines | 13 | 10.83 | Macrolides | 11 | 9.16 | Fluoroquinolones | 10 | 8.34 | Antituberculosis drugs | 8 | 6.67 | Antifungal agents | 4 | 3.34 | Antivirals | 2 | 1.67 | Other† | 4 | 3.34 |
| Cardiovascular agents | Antilipidemic agents | 47 | 39.16 | (Angiotensin-converting enzyme inhibitors (ACEIs) | 40 | 33.34 | Diuretics | 26 | 21.67 | Calcium channel blockers (CCBs) | 17 | 14.16 | Beta blockers (BBs) | 16 | 13.34 |
| Drugs affecting the blood | Antiplatelets | 41 | 34.16 | Anticoagulants | 21 | 17.50 | Antianemics | 9 | 7.50 |
| Gastrointestinal medicines | Antiulcer agents | 16 | 13.34 | Cathartics and laxatives | 8 | 6.67 | Antiemetics | 6 | 5.00 | Vitamins | 8 | 6.67 | Analgesics | 8 | 6.67 | Antidepressants | 6 | 5.00 | Others$ | 4 | 3.34 |
|
|
Drug grouped based on Ethiopian essential medicine lists, 2020. †Clindamycin, meropenem. $Adrenaline, dexamethasone, dopamine, and prednisolone. |